Abstract
Studies of the genomic structure of human T-lymphotropic virus type III (HTLV-III) and related viruses, implicated as the causal agent of acquired immune deficiency syndrome (AIDS), have identified a sixth open reading frame in addition to the five previously known within the genome (gag, pol, sor, env and 3′orf)1–4. This gene, called tat-III, lies between the sorand env genes and is able to mediate activation, in a trans configuration, of the genes linked to HTLV-III long terminal repeat (LTR) sequences5–8. We now present evidence that the product of far-III is an absolute requirement for virus expression. We show that derivatives of a biologically competent molecular clone of HTLV-III9, in which the tat-Ill gene is deleted or the normal splicing abrogated, failed to produce or expressed unusually low levels of virus, respectively, when transfected into T-cell cultures. The capacity of these tat-III-defective genomes was transiently restored by co-transfection of a plasmid clone containing a functional tat-III gene or by introducing the tat-III protein itself. As HTLV-III and related viruses are the presumed causal agents of AIDS and associated conditions10–12, the observation that tat-III is critical for HTLV-III replication has important clinical implications, and suggests that specific inhibition of the activity of tat-III could be a novel and effective therapeutic approach to the treatment of AIDS.
Similar content being viewed by others
References
Ratner, L. et al. Nature 313, 277–284 (1985).
Wain-Hobson, S., Sonigo, P., Danes, O., Cole, S. & Alizon, M. Cell 40, 9–18 (1985).
Sanchez-Pescador, R. et al. Science 227, 484–492 (1985).
Muesing, M. A. et al. Nature 313, 450–458 (1985).
Sodroski, J. G. et al. Science 227, 171–173 (1985).
Arya, S. K., Guo, C., Josephs, S. F. & Wong-Staal, F. Science 229, 69–73 (1985).
Sodroski, J. G., Patarca, R., Wong-Staal, F., Rosen, C. A. & Haseltine, W. A. Science 229, 74–77 (1985).
Rosen, C. A., Sodroski, J. G. & Haseltine, W. A. Cell 41, 813–823 (1985).
Fisher, A. G., Collalti, E., Ratner, L., Gallo, R. C. & Wong-Staal, F. Nature 316, 262–265 (1985).
Gallo, R. C. et al. Science 224, 500–503 (1984).
Barre-Sinoussi, F. et al. Science 220, 868–871 (1983).
Levy, J. A. et al. Science 225, 69–72 (1984).
Nevins, J. R., Ginsberg, H. W., Blanchard, J. M., Wilson, M. C. & Darnell, J. E. J. Virol. 32, 727–733 (1979).
Jones, N. & Shenk, T. Proc. natn. Acad. Sci. U.S.A. 76, 3665–3669 (1979).
Khoury, G. & May, E. J. Virol. 23, 167–176 (1977).
Brady, J. N., Bolen, J. B., Radonovic, M., Slazman, N. & Khoury, G. Proc. natn. Acad. Sci. U.S.A. 81, 2040–2044 (1984).
Benoist, C. & Chambon, P. Nature 290, 304–310 (1981).
Nevins, J. R. Cell 26, 213–220 (1980).
Sodroski, J. G., Rosen, C. A. & Haseltine, W. A. Science 225, 381–385 (1984).
Sodroski, J. G., Rosen, C. A., Goh, W. C. & Haseltine, W. A. Science 228, 1430–1432 (1985).
Chen, I. S. Y. et al. Science 229, 54–57 (1985).
Rosen, C. A., Sodroski, J. G., Kettman, R., Burny, A. & Haseltine, W. A. Science 227, 320–322 (1985).
Derse, D., Caradonna, S. J. & Casey, J. W. Science 227, 317–320 (1985).
Hess, J. L., Clements, J. & Narayan, O. Science 229, 482–485 (1985).
Queen, C. & Baltimore, D. Cell 33, 741–748 (1983).
Seigel, L. et al. Virology 148, 226–231 (1986).
Yoakum, G. H. Biotechniques 25, 24–30 (1984).
Harper, M. E., Marselle, L. M., Gallo, R. C. & Wong-Staal, F. Proc. natn. Acad. Sci. U.S.A. 83, 772–776 (1986).
Muligan, R. C. & Berg, P. Proc. natn. Acad. Sci. U.S.A. 78, 2072–2076 (1981).
Kaufman, J. R. & Sharp, P. A. Molec. cell. Biol. 2, 1304–1319 (1982).
Shaw, G. M. et al. Science 226, 1165–1171 (1984).
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. & Howard, B. H. Proc. natn. Acad. Sci. U.S.A. 79, 6777–6781 (1982).
Veronese di Marzo, F. et al. Virology Proc. natn. Acad. Sci. U.S.A. 82, 5199–5202 (1985).
Maniatis, T., Fitsch, E. F. & Sambrook, J. in Molecular Cloning: A Laboratory Manual, 23–233 (Cold Spring Harbor Laboratory, New York, 1982).
Aldovini, A. et al. Proc. natn. Acad. Sci. U.S.A. (submitted).
Mott, J. E., Grant, R. A., Ho, Y. S. & Plat, T. Proc. natn. Acad. Sci. U.S.A. 82, 88–92 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fisher, A., Feinberg, M., Josephs, S. et al. The trans-activator gene of HTLV-III is essential for virus replication. Nature 320, 367–371 (1986). https://doi.org/10.1038/320367a0
Issue Date:
DOI: https://doi.org/10.1038/320367a0
- Springer Nature Limited
This article is cited by
-
HIV Reservoir: How to Measure It?
Current HIV/AIDS Reports (2023)
-
Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide
The Journal of Membrane Biology (2017)
-
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology
BMC Infectious Diseases (2016)
-
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
Retrovirology (2016)
-
The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway
Microbial Cell Factories (2014)